| 股號 / 名稱 | 總負債 | 淨值 |
| NVS Novartis AG | 54,659,000,000.0 | 39,675,000,000.0 |
| LLY 禮來公司 | 53,234,400,000.0 | 10,771,900,000.0 |
| LH Laboratory Corporation of America Holdings | 8,571,400,000.0 | 7,959,600,000.0 |
| UTHR United Therapeutics Corp | 1,182,200,000.0 | 5,984,800,000.0 |
| ZTS 碩騰 | 9,289,000,000.0 | 4,997,000,000.0 |
| JAZZ Jazz Pharmaceuticals PLC | 7,656,362,000.0 | 3,736,997,000.0 |
| CTLT Catalent Inc | 6,301,000,000.0 | 3,687,000,000.0 |
| NBIX Neurocrine Biosciences Inc | 1,019,400,000.0 | 2,232,000,000.0 |
| RVMD Revolution Medicines Inc | 235,511,000.0 | 1,826,194,000.0 |
| TARO Taro Pharmaceutical Industries Ltd | 384,086,000.0 | 1,779,093,000.0 |
| CRON Cronos Group Inc | 40,514,000.0 | 1,099,571,000.0 |
| PCRX Pacira Biosciences Inc | 704,256,000.0 | 870,130,000.0 |
| RDUS Radius Recycling Inc | 901,092,000.0 | 844,437,000.0 |
| SAGE SAGE Therapeutics Inc | 61,799,000.0 | 705,801,000.0 |
| INVA Innoviva Inc | 568,552,000.0 | 674,955,000.0 |
| CERE Cerevel Therapeutics Holdings Inc | 569,553,000.0 | 673,745,000.0 |
| XNCR Xencor Inc | 283,896,000.0 | 668,796,000.0 |
| LYEL Lyell Immunopharma Inc | 95,077,000.0 | 654,952,000.0 |
| AMPH Amphastar Pharmaceuticals Inc | 873,491,000.0 | 639,421,000.0 |
| VERV Verve Therapeutics Inc | 153,186,000.0 | 599,502,000.0 |
| CRNX Crinetics Pharmaceuticals Inc | 96,247,000.0 | 539,106,000.0 |
| CORT Corcept Therapeutics Inc | 114,812,000.0 | 506,705,000.0 |
| USNA USANA Health Sciences Inc | 135,555,000.0 | 497,202,000.0 |
| RXRX Recursion Pharmaceuticals Inc | 190,263,000.0 | 463,436,000.0 |
| MDGL Madrigal Pharmaceuticals Inc | 235,214,000.0 | 405,333,000.0 |
| CPRX Catalyst Pharmaceuticals Inc | 82,233,000.0 | 387,881,000.0 |
| IONS Ionis Pharmaceuticals Inc | 2,603,386,000.0 | 386,686,000.0 |
| AUPH Aurinia Pharmaceuticals Inc | 170,108,000.0 | 377,954,000.0 |
| ALPN Alpine Immune Sciences Inc | 51,911,000.0 | 327,941,000.0 |
| ORGO Organogenesis Holdings Inc | 181,362,000.0 | 278,663,000.0 |
| NOTV Inotiv Inc | 581,348,000.0 | 254,162,000.0 |
| PRLD Prelude Therapeutics Inc | 40,575,000.0 | 237,090,000.0 |
| CNTA Centessa Pharmaceuticals PLC | 124,002,000.0 | 236,244,000.0 |
| PMVP PMV Pharmaceuticals Inc | 26,463,000.0 | 225,689,000.0 |
| FUSN Fusion Pharmaceuticals Inc | 63,356,000.0 | 222,480,000.0 |
| TBPH Theravance Biopharma Inc | 169,004,000.0 | 212,995,000.0 |
| SIGA SIGA Technologies Inc | 57,493,950.0 | 196,858,910.0 |
| COLL Collegium Pharmaceutical Inc | 947,877,000.0 | 195,431,000.0 |
| ENTA Enanta Pharmaceuticals Inc | 236,615,000.0 | 191,884,000.0 |
| IPSC Century Therapeutics Inc | 175,941,000.0 | 184,750,000.0 |
| ARDX Ardelyx Inc | 130,763,000.0 | 166,816,000.0 |
| ARWR Arrowhead Pharmaceuticals Inc | 465,879,000.0 | 160,407,000.0 |
| SLNO Soleno Therapeutics Inc | 23,184,000.0 | 157,507,000.0 |
| ACRS Aclaris Therapeutics Inc | 40,226,000.0 | 157,179,000.0 |
| NATR Nature's Sunshine Products Inc | 95,715,000.0 | 154,058,000.0 |
| EPIX ESSA Pharma Inc | 3,806,340.0 | 140,682,940.0 |
| SVRA Savara Inc | 37,192,000.0 | 140,372,000.0 |
| ASRT Assertio Holdings Inc | 148,416,000.0 | 138,003,000.0 |
| SAVA Cassava Sciences Inc | 14,195,000.0 | 137,468,000.0 |
| NKTR Nektar Therapeutics | 267,046,000.0 | 130,987,000.0 |
| PYXS Pyxis Oncology Inc | 48,022,000.0 | 125,704,000.0 |
| TNXP Tonix Pharmaceuticals Holding Corp | 48,932,000.0 | 105,525,000.0 |
| RFL Rafael Holdings Inc | 1,210,000.0 | 104,939,000.0 |
| DYN Dyne Therapeutics Inc | 73,790,000.0 | 91,292,000.0 |
| OCUL Ocular Therapeutix Inc | 160,929,000.0 | 91,131,000.0 |
| LYRA Lyra Therapeutics Inc | 53,180,000.0 | 89,420,000.0 |
| VYNE Vyne Therapeutics Inc | 8,950,000.0 | 88,735,000.0 |
| RPHM Reneo Pharmaceuticals Inc | 18,826,000.0 | 88,610,000.0 |
| KALV Kalvista Pharmaceuticals Inc | 25,385,000.0 | 88,583,000.0 |
| AVDL Avadel Pharmaceuticals PLC | 76,959,000.0 | 87,739,000.0 |
| NAII Natural Alternatives International Inc | 70,278,000.0 | 85,455,000.0 |
| RLMD Relmada Therapeutics Inc | 12,194,800.0 | 85,357,240.0 |
| CTXR Citius Pharmaceuticals Inc | 12,665,570.0 | 84,734,250.0 |
| LRMR Larimar Therapeutics Inc | 14,215,000.0 | 81,720,000.0 |
| SMMT Summit Therapeutics Inc | 125,257,000.0 | 77,692,000.0 |
| SCYX SCYNEXIS Inc | 55,450,000.0 | 72,962,000.0 |
| TARA Protara Therapeutics Inc | 10,633,000.0 | 68,321,000.0 |
| MEIP MEI Pharma Inc | 19,050,000.0 | 59,488,000.0 |
| VXRT Vaxart Inc | 34,025,000.0 | 57,805,000.0 |
| PRPH Prophase Labs Inc | 42,544,000.0 | 49,383,000.0 |
| RCEL AVITA Medical Inc | 62,584,000.0 | 49,056,000.0 |
| PMCB PharmaCyte Biotech Inc | 22,465,740.0 | 48,893,660.0 |
| SISI Shineco Inc | 63,379,560.0 | 39,074,340.0 |
| GLYC GlycoMimetics Inc | 6,902,070.0 | 38,414,400.0 |
| SRZN Surrozen Inc | 8,145,000.0 | 37,935,000.0 |
| MDWD Mediwound Ltd | 34,864,000.0 | 31,595,000.0 |
| PROF Profound Medical Corp | 12,731,000.0 | 31,180,000.0 |
| ENLV Enlivex Therapeutics Ltd | 6,747,000.0 | 30,084,000.0 |
| ONCT Oncternal Therapeutics Inc | 6,677,000.0 | 30,052,000.0 |
| CPIX Cumberland Pharmaceuticals Inc | 52,172,630.0 | 29,603,440.0 |
| TBIO Telesis Bio Inc | 40,873,000.0 | 29,538,000.0 |
| TXMD TherapeuticsMD Inc | 14,022,000.0 | 29,287,000.0 |
| TPST Tempest Therapeutics Inc | 24,835,000.0 | 26,768,000.0 |
| ARYD ARYA Sciences Acquisition Corp IV | 14,969,480.0 | 25,683,210.0 |
| CASI CASI Pharmaceuticals Inc | 51,103,000.0 | 24,165,000.0 |
| FNCH Finch Therapeutics Group Inc | 32,487,000.0 | 22,886,000.0 |
| RGLS Regulus Therapeutics Inc | 9,563,000.0 | 21,187,000.0 |
| LPCN Lipocine Inc | 2,631,630.0 | 20,369,440.0 |
| DERM Journey Medical Corp | 56,499,000.0 | 20,350,000.0 |
| AMRX Amneal Pharmaceuticals Inc | 3,452,788,000.0 | 19,781,000.0 |
| VRCA Verrica Pharmaceuticals Inc | 61,834,000.0 | 19,763,000.0 |
| VIRX Viracta Therapeutics Inc | 38,373,000.0 | 18,319,000.0 |
| MRNS Marinus Pharmaceuticals Inc | 154,143,000.0 | 16,765,000.0 |
| DRRX DURECT Corp | 30,406,000.0 | 14,783,000.0 |
| MRKR Marker Therapeutics Inc | 3,074,850.0 | 14,052,540.0 |
| GLMD Galmed Pharmaceuticals Ltd | 2,750,000.0 | 13,879,000.0 |
| BLRX BioLine RX Ltd | 50,702,000.0 | 13,223,000.0 |
| INM InMed Pharmaceuticals Inc | 2,483,250.0 | 12,772,210.0 |
| GANX Gain Therapeutics Inc | 6,031,110.0 | 12,578,220.0 |
| INDP Indaptus Therapeutics Inc | 2,847,380.0 | 12,076,500.0 |
載入數據中...
